ADAMTS13 and thrombotic thrombocytopenic purpura: Upreti et al. concluded that TTP patients in remission exhibiting a lower baseline ADAMTS13 level appear to have an increased risk of ischaemic stroke (13.1% TTP in remission versus 2.6% in the general population).